Restricted expression of oncofetal fibronectin mRNA in thyroid papillary and anaplastic carcinoma: an in situ hybridization study.

Abstract

Restricted expression of oncofetal fibronectin mRNA in the tissues of thyroid papillary and anaplastic carcinoma has recently been shown by both Northern blot analysis and reverse transcriptase polymerase chain reaction (RT-PCR). Oncofetal fibronectin mRNA can be a target of gene diagnosis and targeted gene therapy, provided it is expressed in all cancer cells in the tissues. To investigate this criterion in thyroid cancer tissues, we measured their expression of oncofetal fibronectin mRNA using in situ hybridization. An abundant expression of oncofetal fibronectin mRNA was found in all the observed cancer cells of six papillary carcinomas and an anaplastic carcinoma, but not in the tissues of normal thyroid, Graves' disease, adenomatous goitre, follicular adenoma, follicular carcinoma or medullary carcinoma. This result encourages us to establish gene diagnosis of thyroid papillary and anaplastic carcinomas by detecting oncofetal fibronectin mRNA in biopsies.

• Authors: T Takano, F Matsuzuka, A Miyauchi, T Yokozawa, G Liu, S Morita, K Kuma, N Amino
• Journal: British journal of cancer (Br J Cancer) Vol. 78 Issue 2 Pg. 221-4 (Jul 1998) ISSN: 0007-0920 [Print] England
• PMID: 9683297 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Antigens, Neoplasm
• Fibronectins
• oncofetal antigens

Topics

• Antigens, Neoplasm (genetics)
• Carcinoma (metabolism)
• Carcinoma, Papillary (metabolism)
• Fibronectins (genetics)
• Humans
• In Situ Hybridization
• Thyroid Neoplasms (metabolism)